BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35744792)

  • 21. Exon-skipped dystrophins for treatment of Duchenne muscular dystrophy: mass spectrometry mapping of most exons and cooperative domain designs based on single molecule mechanics.
    Krieger CC; Bhasin N; Tewari M; Brown AE; Safer D; Sweeney HL; Discher DE
    Cytoskeleton (Hoboken); 2010 Dec; 67(12):796-807. PubMed ID: 20886611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup.
    Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K
    Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMD
    Bourdon A; François V; Zhang L; Lafoux A; Fraysse B; Toumaniantz G; Larcher T; Girard T; Ledevin M; Lebreton C; Hivonnait A; Creismeas A; Allais M; Marie B; Guguin J; Blouin V; Remy S; Anegon I; Huchet C; Malerba A; Kao B; Le Heron A; Moullier P; Dickson G; Popplewell L; Adjali O; Montanaro F; Le Guiner C
    Gene Ther; 2022 Sep; 29(9):520-535. PubMed ID: 35105949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center.
    Zhang J; Ma D; Liu G; Wang Y; Liu A; Li L; Luo C; Hu P; Xu Z
    BMC Med Genet; 2019 Nov; 20(1):180. PubMed ID: 31727011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
    Hanson B; Wood MJA; Roberts TC
    RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy.
    Beckers P; Caberg JH; Dideberg V; Dangouloff T; den Dunnen JT; Bours V; Servais L; Boemer F
    Sci Rep; 2021 Feb; 11(1):3011. PubMed ID: 33542429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
    Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DMD and West syndrome.
    Cardas R; Iliescu C; Butoianu N; Seferian A; Gataullina S; Gargaun E; Nectoux J; Bienvenu T; Craiu D; Gidaro T; Servais L
    Neuromuscul Disord; 2017 Oct; 27(10):911-913. PubMed ID: 28802771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of dystrophin expression and correction of Duchenne muscular dystrophy by genome editing.
    Aslesh T; Erkut E; Yokota T
    Expert Opin Biol Ther; 2021 Aug; 21(8):1049-1061. PubMed ID: 33401973
    [No Abstract]   [Full Text] [Related]  

  • 31. A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.
    Sardone V; Ellis M; Torelli S; Feng L; Chambers D; Eastwood D; Sewry C; Phadke R; Morgan JE; Muntoni F
    PLoS One; 2018; 13(3):e0194540. PubMed ID: 29579078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy.
    Wong TWY; Cohn RD
    Curr Gene Ther; 2017; 17(4):301-308. PubMed ID: 29173172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.
    Capitanio D; Moriggi M; Torretta E; Barbacini P; De Palma S; Viganò A; Lochmüller H; Muntoni F; Ferlini A; Mora M; Gelfi C
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):547-563. PubMed ID: 31991054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy.
    Koo T; Wood MJ
    Hum Gene Ther; 2013 May; 24(5):479-88. PubMed ID: 23521559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duchenne and Becker muscular dystrophy: contribution of a molecular and immunohistochemical analysis in diagnosis in Morocco.
    Bellayou H; Hamzi K; Rafai MA; Karkouri M; Slassi I; Azeddoug H; Nadifi S
    J Biomed Biotechnol; 2009; 2009():325210. PubMed ID: 19461958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.
    Walmsley GL; Arechavala-Gomeza V; Fernandez-Fuente M; Burke MM; Nagel N; Holder A; Stanley R; Chandler K; Marks SL; Muntoni F; Shelton GD; Piercy RJ
    PLoS One; 2010 Jan; 5(1):e8647. PubMed ID: 20072625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan.
    Chien YH; Lee NC; Weng WC; Chen LC; Huang YH; Wu CS; Hwu WL
    Neurol Sci; 2022 Jul; 43(7):4563-4566. PubMed ID: 35562557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.
    Marini M; Salmi AA; Watihayati MS; SMardziah MD; Zahri MK; Hoh BP; Ankathil R; Lai PS; Zilfalil BA
    Med J Malaysia; 2008 Mar; 63(1):31-4. PubMed ID: 18935728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal diagnosis of Duchenne muscular dystrophy revealed a novel mosaic mutation in Dystrophin gene: a case report.
    Wang Y; Chen Y; Wang SM; Liu X; Gu YN; Feng Z
    BMC Med Genet; 2020 Nov; 21(1):222. PubMed ID: 33176713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.